Clinical Trial Update: SHARE: Simple HAART With Abacavir, Reyataz, and Epivir [Phase 4]

View source ↗

Summary

Phase 4 trial update of a simple HAART regimen using abacavir, atazanavir, and lamivudine for HIV infection with lipodystrophy; the current status of the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Lipodystrophy

Drugs mentioned

• Epivir (lamivudine) (lamivudine)
• Reyataz (atazanavir) (atazanavir)
• Ziagen (abacavir) (abacavir)

Snippet

Sponsor: Clinical Alliance for Research & Education - Infectious Diseases, LLC. | Conditions: HIV Infections, Lipodystrophy | Phase 4 | Status: UNKNOWN